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Background: Medicare’s mandatory bundle for hip and knee arthroplasty necessitates provider 
accountability for quality and cost of care to 90 days, and wound closure may be a key area of 
consideration. The DERMABOND® PRINEO® Skin Closure System (22 cm) combines a topi-
cal skin adhesive with a self-adhering mesh without the need for dressing changes or suture or 
staple removal. This study estimated the budget impact of the Skin Closure System compared 
to other wound closure methods for hip and knee arthroplasty.
Methods: A 90-day economic model was developed assuming 500 annual hip/knee arthroplas-
ties for a typical US hospital setting. In current practice, wound closure methods for the final 
skin layer were set to 50% sutures and 50% staples. In future practice, this distribution shifted 
to 20% sutures, 20% staples, and 60% Skin Closure System. Health care resources included 
materials (eg, staplers, steri-strips, and traditional/barbed sutures), standard or premium dress-
ings, outpatient visits, and home care visits. An Expert Panel, comprised of three orthopedic 
physician assistants, two orthopedic surgeons, and a home health representative, was used to 
inform several model parameters. Other inputs were informed by national data or literature. 
Unit costs were based on list prices in 2016 US dollars. Uncertainty in the model was explored 
through one-way sensitivity and alternative scenario analyses.
Results: The analysis predicted that use of Skin Closure System in the future practice could 
achieve cost savings of $56.70 to $79.62 per patient, when standard or premium wound dress-
ings are used, respectively. This translated to an annual hospital budgetary savings ranging from 
$28,349 to $39,809 when assuming 500 arthroplasties. Dressing materials and postoperative 
health care visits were key model drivers.
Conclusions: Use of the Skin Closure System may provide cost savings within hip and knee 
arthroplasties due to decreases in resource utilization in the postacute care setting.
Keywords: budget impact analysis, wound closure, knee arthroplasty, hip arthroplasty, hospital, 
economic, wound dressings, costs, postacute care
Introduction
Wound complications are one of the major sources of morbidity and costs related 
to arthroplasty procedures, including dehiscence, infection, inflammation, necrosis, 
abscess, and blistering.1–4 Surgical site complications (including infection, dehis-
cence, and disruption) have been reported as a key reason for readmissions, with over 
30% of 30-day readmissions in total hip arthroplasty and total knee arthroplasty.5–9 
Alone, surgical site infections (SSIs) are associated with serious outcomes, such as 
increased mortality and pose a significant economic burden.5 Another factor potentially 
impacting the occurrence of wound complications is wound perfusion.10 Depending 
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on the method used for arthroplasty closure, perfusion and 
subsequent wound healing can either be improved (ie, using 
running sutures) or hindered (ie, using staples).10
In addition to current methods of wound closure such as 
sutures or staples, wound dressings are necessary for proper 
wound management.11 However, wound dressings are not 
intended for wound closure and therefore lack the required 
strength. In addition, several wound dressings require dress-
ing changes which can be painful, time-consuming, increase 
pathogen exposure, and delay wound healing.11,12 In hip 
and knee arthroplasty, wound dressings are reported to be 
typically changed three to five times on average, which can 
impose a significant cost burden.4,13
The DERMABOND® PRINEO® Skin Closure System 
(22 cm) (Ethicon U.S., LLC, Somerville, NJ, USA) (ie, Skin 
Closure System) is a novel skin closure device that combines 
a topical skin adhesive (TSA) (2-octyl cyanoacrylate) with a 
self-adhering mesh.14 This design provides a wound closure 
method without the need for dressing changes. Also, the 
Skin Closure System has been proved to be 99% effective 
through 72 hours in vitro as a microbial barrier against 
bacteria most commonly associated with SSI, including 
Staphylococcus aureus, Pseudomonas aeruginosa, Esch-
erichia coli, Enterococcus faecium, and  Staphylococcus 
epidermidis.15 Four randomized trials have evaluated the Skin 
Closure System across a variety of surgery types.16–19 These 
randomized studies have demonstrated comparable wound 
closure efficacy16,17 and lower skin closure and procedure time 
relative to sutures.16–18 Furthermore, the Skin Closure System 
has also been shown to provide good cosmetic results up to 
1 year,16–18 less pain at removal compared to other wound 
closure methods,18 and the ability for patients to shower 
immediately after procedure if directed by their health care 
practitioner.18 The TSA  component has also been extensively 
studied in over 40 randomized trials, including within hip 
and knee arthroplasty.20–23
Recently, the Centers for Medicare & Medicaid Services 
(CMS) implemented the first mandatory bundle for hip and 
knee arthroplasty in 67 regions across the USA, which neces-
sitates provider accountability for quality and cost of care 
to 90 days.24,25 Within the context of this health care reform 
environment, decision makers need to consider products that 
provide the best clinical outcomes, while balancing budgets. 
As such, the objective of this study was to conduct a 90-day 
budget impact analysis from the hospital provider perspec-
tive of the Skin Closure System compared with other wound 
closure methods (ie, sutures and staples) for hip and knee 
arthroplasty in the USA.
Methods
Model design
A budget impact model with a 90-day time horizon was devel-
oped using Microsoft Excel 2013 (Microsoft Corporation, 
Redmond, WA, USA) to estimate the total costs of wound 
closure methods for final skin layer closure in hip and knee 
arthroplasty procedures from a US hospital provider perspec-
tive, including acute and postacute care. The model assumed 
that 500 hip and knee arthroplasty procedures are performed 
annually at a facility. The model was developed in accordance 
with recommendations from the International Society for 
Pharmacoeconomics and Outcomes Research (ISPOR) Task 
Force Report: Budget Impact Analysis whenever possible.26
The model compared final skin layer wound closure mate-
rials, dressings, and postoperative visit costs between a current 
and future scenario in hip and knee arthroplasty procedures. 
The current scenario for wound closure methods primarily 
comprised staples and sutures, while the future scenario 
included the adoption of the Skin Closure System. In the 
current scenario, the model specifically assumed 50% use of 
staples and 50% use of sutures, as per US Premier Perspective® 
Database findings.27 In the future scenario, the model assumed 
60% of arthroplasties would be treated with the Skin Closure 
System, 20% with staples, and 20% with sutures. Details of 
all model input values are provided in Table 1.
Expert panel
In the published literature, there is a lack of information on 
the steps involved in wound closure and postoperative care in 
hip and knee arthroplasty. To obtain a detailed understanding 
of these processes, expert opinion was sought. To character-
ize the treatment practices of wound closure care in hip and 
knee arthroplasty, from beginning to end, a 31-item survey 
was developed based on literature gaps and administered via 
teleconference individually with each expert. Although the 
survey is not a formally validated questionnaire, a face-to-
face meeting was held with the expert panel after the first 
set of answers was obtained to help ensure face validity. The 
panel consisted of two orthopedic surgeons, three physician 
assistants that specialize in orthopedic surgeries, and one 
home health agency representative. The panel was used to 
determine typical resource use for hip and knee arthroplasty 
procedures over a 90-day period for wound closure with 
staples, sutures, or Skin Closure System. For the model, sev-
eral inputs for wound closure materials, dressing materials, 
and postoperative visits were informed by the panel. If vari-
ability existed in clinician responses, a mean value was used 
where possible and variability tested in alternative scenarios.
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Closure materials
Materials used for wound closure varied by closure method. 
Each closure method consisted of a primary product, which 
was used in all patients, and optional products that could 
be used adjunctively. The proportion of use for primary or 
optional materials was informed by the expert panel, analysis 
from the Premier Perspectives® Database, or through model 
assumptions.27 The number of units used for each product was 
gathered from the expert panel. Unit costs were determined 
from list prices.28 For closure with staples, the primary mate-
rial was denoted to be a disposable stapler and the optional 
material included steri-strips. The expert panel predicted that 
90% of cases would require a single stapler, whereas 10% of 
cases would require two, for a weighted average of 1.1 units 
per procedure. Added to the cost of staples was a single unit 
for a staple removal kit. The panel also determined all patients 
receiving staples were assumed to use steri-strips, with only 
a single package used each case.
Table 1 summary of model inputs by closure method for base case scenario: materials, dressings, and postoperative visits in 90 days
Model parameters Staples Sutures Skin Closure System
Materials used for final skin layer
Materials staples steri‑strips Traditional 
suturea
Barbed 
suture
Traditional 
Tsa
skin 
closure 
system
Traditional 
sutureb
Barbed  
suture
Classificationc Primary Optional Primary Primary Optional Primary Optional Optional
Proportion usec,27 (%) 100 100 95 5 15.1 100 45 5
number of unitsc 1.1 1.0 1.0 1.0 2.0 1.0 1.0 1.0
Unit cost28 ($) 43.89 0.74 15.96 37.04 37.76 140.92 15.44 37.04
Dressing usage within 90 days
Dressing type standard Premium standard Premium The skin Closure system does 
not require dressings or dressing 
changes
Unit cost31,32 ($) 2.97 58.99 2.97 58.99
Units for unitial dressing applicationc 1.0 1.0 1.0 1.0
number of inpatient dressing changesc 1.0 0 1.0 0
Units per inpatient dressing changec 1.0 0 1.0 0
number of outpatient dressing changesc 5.0 0 5.0 0
Units per outpatient dressing changec 1.0 0 1.0 0
Postoperative visits within 90 days
Outpatient visits
Visit cost29 ($) 117.50
Proportion of patients with visitsc (%) 100 100 100
number of visits per patientc 3 3 2
home health nurse visits
Visit cost30 ($) 134.42
Proportion of patients with visitsc (%) 50 50 50
number of visits per patientc 3 3 2
Notes: One base case scenario assumed standard dressings, whereas the other assumed premium dressings. aTraditional sutures included a combination of absorbable (ie, 
monocryl) and nonabsorbable (ie, nylon) sutures. bTraditional sutures included only absorbable sutures (ie, monocryl) as nonabsorbable sutures are not compatible with the 
skin Closure system. cinputs determined by clinical opinion from Expert Panel.
For closure with sutures, the panel identified the primary 
materials to be traditional or barbed sutures and estimated 
breakdown of use. Traditional sutures were assumed to be 
used in 95% of cases and barbed sutures were used in the 
remaining 5%, with one suture unit used for all types. Tradi-
tional sutures comprised  absorbable (ie, monocryl) and non-
absorbable (ie, nylon) sutures. All traditional suture patients 
were assumed to have absorbable sutures, with 5% of cases 
additionally requiring adjunctive nonabsorbable sutures. For 
optional materials, the panel identified TSAs as a potential 
adjunctive treatment with traditional or barbed sutures. The 
panel was not able to reach a consensus on the proportion 
of TSA use, so the US Premier Perspectives® Database was 
used to determine that 15.1% of suture cases require TSA.27 
The panel estimated that an average of two TSA units are 
used per procedure.
Closure with the Skin Closure System was estimated 
to require one unit on average. For optional materials, the 
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panel proposed sutures could be used adjunctively in 50% of 
cases. Although closure with the Skin Closure System does 
not require subcuticular suture use, the panel estimated that 
some users would still place these sutures, especially in higher 
tension knee procedures. It was further assumed that of suture 
use, 90% would involve traditional sutures (absorbable only, 
as nylon sutures cannot be used with Skin Closure System) 
and 10% would involve barbed sutures, with one unit used 
on average for either suture type.
Postoperative visits
The model considered postoperative costs over the 90-day 
period with the types of visits impacted by wound closure 
method being identified by the panel of experts. These 
included outpatient and home health nurse visits.
For outpatient visits, the panel agreed all patients would 
return for an average of 3 visits during the 90-day period 
with staples or sutures. This consisted of a visit at: 2 weeks, 
6 weeks, and 3 months. The panel predicted that the use 
of the Skin Closure System as the primary wound closure 
method could reduce the number of visits by one visit. With 
outpatient visits, the cost per visit was assumed to be the 
same regardless of wound closure method and was calculated 
from the literature (cost per physician office visits during 
peri-operative period).29
With home health nursing visits, the panel was not able to 
estimate the proportion of arthroplasty patients receiving this 
service. The panel noted that hospitals would either have all 
patients or no patients receive home nursing care. The model 
default used the average as an assumption, with 50% of patients 
receiving home health visits during the 90-day follow-up. Simi-
larly for outpatient visits, the panel estimated that the number 
of home health nursing visits during the 90-day period would 
be 3 on average for staples and sutures. This number could be 
reduced by one visit with the use of the Skin Closure System 
as the primary wound closure method. The cost of health nurse 
visits was taken from the Low Utilization Payment Adjustment 
rate for skilled nursing as reported by CMS.30
Dressing materials
The panel confirmed that wound dressings are commonly 
used following hip and knee arthroplasties. The model 
assumed dressings were required for all patients receiv-
ing staples or sutures for wound closure and that dressings 
were not required for patients treated with the Skin Closure 
System, as per its instruction for use.14 The panel identified 
that dressings could be used at different stages throughout 
the 90-day follow-up period, including: 1) the initial applica-
tion after the arthroplasty procedure; 2) applications during 
inpatient stay; and 3) applications during outpatient care. 
The number of dressings used, and the frequency of dressing 
changes were assumed to depend on the type of dressing. 
The types of dressings were classified into two categories: 
standard and premium.
Standard dressings were assumed to be simple wound 
closure products, such as generic 4×4 gauze pads. The panel 
estimated that these products required a single unit during 
each application and that there was one dressing change 
during inpatient stay as well as 5 dressing changes in an out-
patient setting. Premium dressings were assumed to be more 
advanced products that may possess antimicrobial properties. 
The panel further estimated that these products required a 
single unit during the initial application and required no 
dressing changes during inpatient stay or outpatient set-
ting. Unit costs for standard and premium dressings were 
taken from RED BOOK Online average wholesale prices 
for  Tegaderm™ HP Transparent Dressing and Aquacel® Ag 
Surgical Hydrofiber, respectively.31,32
The panel could not estimate the proportion of cases 
where standard vs premium dressings were utilized. Based 
on this, two analyses were modeled, one where only standard 
dressings were used and the other where only premium dress-
ings were used (all other inputs relating to wound closure and 
postoperative care were identical between the two analyses).
Modeled analysis
Two base case (ie, most likely) scenarios were analyzed using 
model input values from Table 1. The distinction between the 
two scenarios was that one included only standard dressings 
and the other included only premium dressings. For each of 
the base case scenarios, several one-way sensitivity analyses 
were performed by increasing or decreasing the default model 
input values, one parameter type at a time, by 20%.
Several additional scenarios, some of which varied mul-
tiple inputs at a time, were also modeled to test potential 
variations in current market-share as well as uptake rates 
of the Skin Closure System (see Table 2). Extreme values 
for certain treatment practices were also tested in scenario 
analyses. This included the assumption of no difference in 
the number of outpatient visits, home health nurse visits, or 
both (multi-way), between comparators. Scenarios were also 
evaluated which assumed that either 0% or 100% of patients 
received home health nurse visits, as this practice is expected 
to dichotomously vary across settings.
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Results
Base case scenario
Assuming 500 annual hip and knee arthroplasty procedures, 
the model predicted that a 60% uptake of the Skin Closure 
System could be cost saving to the hospital provider, regard-
less of the type of wound dressing (ie, standard or premium) 
used in the facility. Specifically, the model predicted that a 
facility using standard (low-cost) dressings may anticipate 
annual savings of $28,349 ($56.70 per patient). When a facil-
ity uses premium (higher-cost) dressings, an annual savings 
of $39,809 ($79.62 per patient) was predicted. In both analy-
ses, the increased wound closure material costs were offset 
by reductions in the costs associated with dressing materials 
and postoperative visits (Figure 1; Table 3).
sensitivity analysis results
The results of the one-way sensitivity analysis, where 
parameters were varied by 20%, are presented in Figure 2. 
The model conclusions remained robust, with cost savings 
predicted across all scenarios tested. The results were most 
Table 2 Market‑share scenarios for base case and alternative scenario analyses
Cost types Staples Sutures Skin Closure System
 Current (%) Future (%) Current (%) Future (%) Current (%) Future (%)
Base case analysis 50 20 50 20 0 60
alternative scenario 1 50 0 50 0 0 100
alternative scenario 2 100 0 0 0 0 100
alternative scenario 3 0 0 100 0 0 100
Figure 1 graphical summary of 90‑day wound closure‑related cost results for 500 hip and knee arthroplasty procedures in a current vs future scenario.
Notes: Results are provided for both standard dressing (A) and premium dressing analysis (B). a negative value indicates cost savings for future vs current scenario.
$350,000
$300,000
$250,000
$200,000
$150,000
$100,000
$50,000
To
ta
l c
os
t
$0
–$50,000
$350,000
B
A
$300,000
$250,000
$200,000
$150,000
$100,000
$50,000
To
ta
l c
os
t
$0
–$50,000
–$100,000
Current practice Future practice Incremental
Current practice Future practice Incremental
Total incremental costs
Postoperative visit costs
Dressing costs
Closure material costs
Total incremental costs
Postoperative visit costs
Dressing costs
Closure material costs
 
Cl
in
ico
Ec
on
om
ics
 a
nd
 O
ut
co
m
es
 R
es
ea
rc
h 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
7.
14
0.
23
3.
16
 o
n 
23
-J
an
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
ClinicoEconomics and Outcomes Research 2019:11submit your manuscript | www.dovepress.com
Dovepress 
6
Dovepresssadik et al
Table 3 Detailed summary of 90‑day wound closure‑related cost results for 500 hip and knee arthroplasty procedures in a current 
vs future scenario
Cost types Current scenario costs ($)a Future scenario costs ($)b Incremental
standard dressing
Closure material 19,359 52,660 33,301
Dressing material 10,395 4,158
−6,237
Postoperative visit 277,065 221,652
−55,413
Total cost per population 306,819 278,470
−28,349
Premium dressing
Closure material 19,359 52,660 33,301
Dressing material 29,495 11,798
−17,697
Postoperative visit 277,065 221,652
−55,413
Total cost per population 325,919 286,110
−39,809
Notes: Results are provided for both standard dressing and premium dressing analysis. negative values indicate cost savings for the future vs current scenario analysis. 
aassumes 50% use of both sutures and staples.27 bassumes 20% suture use, 20% staple use, and 60% skin Closure system use.
Figure 2 One‑way sensitivity results on the base case analysis for standard dressings (A) and premium dressings (B) for 500 hip and knee arthroplasty procedures. a negative 
value indicates cost savings for future vs current scenario. 
Note: The center line represents the base case incremental cost between the current and future analysis scenarios.
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sensitive to changes in the number of units or unit costs of 
the Skin Closure System. Results were also sensitive to the 
number and costs of health care visits. As demonstrated by 
the bottom of the tornado diagram, results were least sensi-
tive to changes in the number of units and costs of staples 
and sutures.
Of the 16 alternative scenarios tested, 13 were predicted 
to be cost saving (Figure 3). For the market-share scenarios, 
increasing the adoption of the Skin Closure System was 
predicted to increase cost savings to the hospital provider, 
irrespective of whether sutures or staples were the main 
comparator. For health care visit scenarios, the presence or 
absence of home nurse visits as part of a hospital protocol 
did not change the directionality of the results. Results were 
sensitive to whether differences in health care visits (ie, 
outpatient or home health nurse) between comparators were 
assumed, particularly when assuming no difference in both 
outpatient visits and home health nursing visits. However, 
in the scenarios that predicted a cost impact with increased 
adoption of the Skin Closure system, cost offsets were still 
seen, with the increased material costs associated with use 
of the Skin Closure System being offset by reduced dress-
ing costs.
Discussion
The model demonstrated that the adoption of a novel wound 
closure device may provide important cost savings in hip and 
knee arthroplasty procedures to hospital providers during the 
critical 90-day postacute care period associated with bundled 
payments. These findings are a result of reduced healthcare 
resource utilization, particularly associated with dressing 
changes and postacute care visits, with increased uptake of 
the Skin Closure System relative to the current standard of 
care of sutures and staples. Specifically, the model predicts 
an annual cost savings of $28,349 to $39,809 per 500 hip or 
knee arthroplasty related to wound closure and care-related 
Figure 3 additional scenario results with standard dressings (A) and premium dressings (B) for 500 hip and knee arthroplasty procedures. 
Notes: scenario results report the incremental costs between current and future scenarios. a negative value indicates cost savings with the future scenario.
Abbreviations: C, current; F, future; hhn, home health nurse; OP, outpatient; s, scenario; sCs, skin Closure system.
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costs when there is a 60% uptake of the Skin Closure System. 
Our study further contributes to the literature by providing a 
detailed hospital budget impact assessment of a novel device 
in hip and knee arthroplasty as there is a dearth of economic 
literature in this area.
As costs and practices can vary by hospital, a range of 
sensitivity analyses and alternative scenarios were performed 
to explore uncertainty within the model. One-way sensitivity 
analyses highlighted that model results consistently showed 
cost savings with increased uptake of the Skin Closure 
System across upper and lower ranges of model parameters. 
Additional scenario analyses explored variations in model 
parameters that may reasonably vary across facilities in the 
USA, including whether sutures, staples or both are used as 
current practice, whether home health care visits by nurses 
are part of standard hospital protocol, and the level of uptake 
of the Skin Closure System in future practice. Many of these 
alternative scenarios predicted similar results to the original 
base case assumptions. Finally, several scenarios tested the 
impact of reducing the benefit of the Skin Closure System 
on outpatient and/or home health care nurse visits. In some 
of these scenarios, the incremental results for the future vs 
current scenario changed from cost saving to cost impact; 
however, this largely occurred when it was conservatively 
assumed that the Skin Closure System was associated with 
no reduction in any type of visit. In these scenarios, the 
increased costs associated with the Skin Closure System 
were still offset due to reduced dressing-related costs. The 
results of these analyses capture some of the potential vari-
ability in treatment patterns, resource use, and costs that may 
occur across hospitals and demonstrate the robustness of the 
economic benefits of the Skin Closure System.
According to Sharma et al, the ideal dressing for hip and 
knee arthroplasty wounds is that the dressing should be able 
to act as a microbial barrier while handling excess wound 
exudate, enable freedom of movement, accommodate joint 
flexion, enable wound visibility through the dressing, and 
allow for atraumatic dressing changes and removal.33 The 
Skin Closure System has several of these characteristics, that 
is, it is capable of eliminating the need for dressing changes 
altogether, and, unlike standard dressings, and is a method 
for wound closure.34,35 Evidence has shown that products that 
reduce the number of dressing changes may reduce costs even 
with increased acquisition costs.36 As wound dressings typi-
cally need to be changed three to five times in arthroplasty, 
reducing dressing changes saves material costs, staff time, 
reduces the delay in cellular activity for wound healing, and 
reduces the risk for pathogen exposure during the dressing 
changes.4,11,13 Reducing potential pathogen exposure can 
have significant economic benefits by reducing the risk of 
SSI, which is associated with total costs 3- to 4-fold higher 
compared to procedures without SSIs.5,37,38 The Skin Closure 
System provides additional benefits with its significantly 
greater skin-holding strength and better tension distribu-
tion across the wound compared to staples or sutures.39,40 
Additionally, the Skin Closure System provides a breadth of 
patient benefits including the ability to shower immediately 
following surgery if directed by their health care professional, 
good cosmetic results, easy self-care since no postsurgical 
dressings are needed, designed to provide microbial barrier 
protection, no suture or staple removal, and less pain on 
removal.14–18,35
Additional evidence has shown the ability of the Skin 
Closure System to improve knee arthroplasty outcomes in 
a clinical setting.41 In a recent retrospective study of 1,942 
total knee arthroplasty patients, statistically significant reduc-
tions were reported in 30-, 60-, 90-day all cause readmission 
rates, length of hospital stay, and probability of discharge to 
a skilled nursing facility or other nonhome setting with the 
Skin Closure System compared with skin staples.41 With a 
30-day, all-cause readmission costing $12,839 and penalties 
of up to 3% of total inpatient Medicare revenue for worse-
than-average readmission rates for knee arthroplasty, these 
results have important implications for total cost savings to 
US hospitals.42–44 The findings from this study further sup-
port the results of our modeling work, indicating postacute 
care sources of cost-savings with the Skin Closure System.
Given the current health care reform and bundled payment 
initiatives established by CMS for hospital reimbursement 
of hip and knee arthroplasty, the Skin Closure System offers 
a unique opportunity to both reduce health care costs and 
improve patient outcomes and satisfaction.24,25 With bundled 
payment, hospitals are reimbursed at a flat rate per episode 
of care as opposed to reimbursement based on the specific 
treatments provided. This new system creates an incentive 
for organizations to become more coordinated in providing 
the best care possible to patients rather than focusing on the 
quantity of services provided.45 In the context of all health 
care reform programs collectively, the adoption of health care 
technologies that are clinically superior, cost-effective, and 
patient-focused is critical for hospitals to succeed in meeting 
the principles of the Triple Aim: improve patient experience/
outcomes, improve health, and reduce costs.46
Despite efforts to accurately reflect clinical practices for 
knee and hip arthroplasties, the model inputs are largely based 
on clinical opinion from a panel of experts and therefore 
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 caution must be taken in generalizing results across US pro-
vider situations. However, this methodology was necessary 
given the lack of published information on the process of 
wound closure care for these procedures. This need for cau-
tion is mitigated through the variability in experience among 
panel members, as panel members included a mix of those 
who currently do and do not use the Skin Closure System. 
The numerous sensitivity and scenario analyses help address 
this issue by accommodating the potential variety of provider 
processes of care. The use of expert opinion and surveys is 
also consistent with the ISPOR guidelines for determining 
inputs relating to practice patterns.26 Additionally, the meth-
ods for obtaining information from the expert panel included 
a very detailed and progressive set of steps to optimize the 
completeness and accuracy of the data, including discussion 
of survey questions during a teleconference as well as an 
in-person meeting. Future research with an expanded set of 
clinical experts across regions may help validate our findings.
A further limitation of the study was that the sensitivity 
analyses used arbitrary thresholds of ±20% to assess impact 
of lower and upper ranges on parameter values. However, due 
to the limited literature available, considering the basis of 
variation in the analysis on known alternative values was not 
always possible. At a minimum, the use of this method is ben-
eficial for identifying the most impactful parameters which 
can inform decision-making. As well, additional scenario 
analyses help to capture the range of variability in a different 
way by testing the impact of model structural uncertainty and 
potentially different hospital facility scenarios, such as with 
the unknown uptake rates of the Skin Closure System. Both 
one-way sensitivity analyses and scenario analyses on struc-
tural uncertainty are recommended when conducting budget 
impact analyses.26 Another potential source of structural 
uncertainty was regarding whether all possible parameters 
were in fact included in the model. Due to limited data, certain 
parameters, such as risk of infection, could not be modeled. 
This analysis may therefore be considered conservative in 
terms of the potential economic benefits the Skin Closure 
System has relative to standard care. Further data on such 
outcomes can help to complete the economic assessment of 
this product in hip and knee arthroplasty.
The current study provides a novel perspective on the 
cost analysis of hip and knee arthroplasty procedures not 
currently found in the literature. Despite a wealth of research 
on skin adhesives, staples and various types of sutures, very 
little is available regarding devices such as the Skin Closure 
System, and even less is available concerning their economic 
benefits. With the inclusion of all currently available cost 
data in the model and the rigorous sensitivity and scenario 
analyses conducted, this study demonstrated that the Skin 
Closure System may have important economic benefits in 
the postacute care setting.
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